Onco-Innovations’ licensed technology demonstrates promise to enhance chemotherapy effectiveness by overcoming cancer cell resistance: Vancouver, BC Saturday, February 1, 2025, ...

which enhance the effectiveness of chemotherapy by making cancer cells more sensitive to topoisomerase I poisons. This advancement could improve patient outcomes by directly inhibiting cancer ...

and Investigation of Isomerically Hydroxylated Indenoisoquinoline Analogues as Topoisomerase I Poisons Potentiation of the novel topoisomerase I inhibitor indenoisoquinoline LMP-400 by the cell ...